Clearstead Advisors’s Zai Lab ZLAB Stock Holding History

Clearstead Advisors’s Portfolio ZLAB Stock Details ZLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9	Closed	-$170	–	3737
2026 Q1	$170	Hold	9	–	–	﹤0.01%	2178
2025 Q4	$159	Buy	+9	New	+$211	﹤0.01%	2449

Other funds holding ZLAB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

NFT

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

PFM

Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

Clearstead Advisors's ZLAB Position: Q2 2026 in Review

Clearstead Advisors sold out of Zai Lab (ZLAB) in Q2 2026, closing a stake of 9 shares — an estimated $170 sold.

Clearstead Advisors first reported a position in ZLAB in Q4 2025 and held it in 2 quarters. The position peaked at $170 in Q1 2026. 28 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.

Clearstead Advisors reported no remaining Zai Lab position as of Q2 2026 after selling out during the quarter.
Clearstead Advisors sold 9 Zai Lab shares in Q2 2026, an estimated $170.
Clearstead Advisors first reported a position in Zai Lab in Q4 2025 and held it in 2 quarters.
Clearstead Advisors's Zai Lab position peaked at $170 in Q1 2026.
28 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.